Stay up to date

Our latest press releases

02/22/2024

Wörwag Pharma: success instead of bottle necks

Böblingen, February 22, 2024 – Wörwag Pharma closed the 2023 financial year with an organic sales growth of 7.6 percent – despite the tense situation…

Read press information

01/22/2024

Mauermann becomes Wörwag Pharma Production

Böblingen, January 22, 2024 – With the renaming of the most recent investment Mauermann Arzneimittel GmbH & Co. KG, Wörwag Pharma is taking the next…

Read press information

03/16/2023

Wörwag Pharma invests in further growth

Böblingen, March 16, 2023 – The Böblingen-based pharmaceutical and family-owned company Wörwag Pharma closed the 2022 financial year with an increase…

Read press information

02/17/2022

Wörwag Pharma invests in own production

Böblingen, February 17, 2022 – The Boeblingen-based family-owned company Wörwag Pharma invested in several strategic milestones in 2021 and…

Read press information

11/13/2021

Fritz-Wörwag-Research-Prize: New scientific findings from biofactor research honored

In order to support science and research, Wörwag Pharma has awarded the 10th Fritz Wörwag Research Prize this year. The prize rewards new research…

Read press information

05/04/2021

Wörwag Pharma acquires production company in Poland

Böblingen/Lódz – German pharmaceutical company Wörwag Pharma GmbH & Co. KG announces the acquisition of Sensilab, contract manufacturer and…

Read press information

Your contact

Monika Wörwag

Director Corporate Communications

press@woerwagpharma.com